Expands support for people with sickle cell disease and its complications.
This bill would renew and expand a federal program that helps people with sickle cell disease. It would set aside more money for the program and allow it to cover the treatment of disease complications. This means more comprehensive care could be available for those affected.
Currently, a federal program helps with sickle cell disease prevention and treatment, authorized at $4,455,000 per year from 2019 to 2023. If this bill passes, the program would be renewed and receive $8,205,000 per year from 2025 to 2029, nearly doubling its funding. Its focus would also expand to specifically cover the treatment of sickle cell disease and its complications, and the administering agency could use grants and cooperative agreements in addition to contracts.
HR 1796 · 119th Congress · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers
8 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.